NGS Sample Preparation Market - A Global and Regional Analysis

Focus on Product, Workflow, Therapeutic Area, Application, End User, and Region - Analysis and Forecast, 2021-2026

Published Year:
SKU:BHP0753SB
Get Customization, Data Extraction and Value Added Services with All BIS Research Reports
Know More

$5250

Online Access for 1-3 Users. Permission to Print.


In case you require a hard copy, there will be an additional charge of $500. Please email us at [email protected] with your request.

A quick peek into the report

Market Report Coverage

NGS Sample Preparation Market
Forecast Period: 2021-2026
CAGR During Forecast Period: 14.24%

NGS Sample Preparation Market

Base Year

2020

Market Size in 2021

$1,685.6 Million

Forecast Period

2021-2026

Value Projection and Estimation by 2026

$3,279.3 Million

CAGR During Forecast Period

14.24%

Number of Tables

10

Number of Pages

294

Number of Figures

268

Market Segmentation

•    Product (Consumables, Standalone Automation Instruments, Automated Workstation, Accessories and Components)

•    Workflow (Library Preparation, Target Enrichment, Sample Extraction/Isolation, Fragmentation, Sample Quantification, Library Quantification, Quality Control (QC), and Pooling)

•    Therapeutic Area (Oncology, Infectious Diseases, Human Genetics/Population Genetics, and Others)

•    Application (DNA Sequencing, Whole Genome Sequencing, RNA Sequencing, Methylation Sequencing, and Others)

•    End User (Hospitals and Clinics, Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, and Others)

Regional Segmentation

•    North America: U.S., Canada

•    Europe: Germany, France, U.K., Italy, Spain, Netherlands, Denmark, Belgium, Switzerland, and Rest-of-Europe

•    Asia-Pacific: China, Japan, India, South Korea, Australia, Singapore, and Rest-of-Asia-Pacific

•    Latin America: Brazil, Mexico, and Rest-of-Latin America

•    Rest-of-the-World

Market Growth Drivers

•    Increasing Use of NGS for Genetic Disorders

•    Technological Advancements in NGS Sample Preparation Methods

•    Rising Research Funding in the Field of Genomics

Market Challenges

•    High Cost of Automated NGS Sample Preparation Instruments

•    Dearth of Skilled Professionals and Lack of Infrastructure in Emerging Countries

•    Stringent Regulatory Standards

Market Opportunities

•    Adoption of Automated NGS Sample Preparation in the Emerging Markets

•    Rising Direct-to-Consumer Testing

Key Companies Profiled

Agilent Technologies, Inc., Aurora Biomed Inc., Danaher, Bio-Rad Laboratories, Inc., Eppendorf SE, Opentrons, BGI Group, Promega Corporation, Oxford Nanopore Technologies plc., F. Hoffmann-La Roche Ltd, Tecan Trading AG, Hamilton Company, PerkinElmer Inc., Illumina, Inc., Thermo Fisher Scientific Inc., New England Biolabs, QIAGEN, Pacific Biosciences of California, Inc.

Key Questions Answered in this Report:

How is the COVID-19 pandemic impacting the global NGS sample preparation ecosystem?

•    How is NGS sample preparation revolutionizing oncology?
•    What are the major market drivers, challenges, and opportunities in the global NGS sample preparation market?
•    What are the underlying structures resulting in the emerging trends within the global NGS sample preparation market?
•    How is the COVID-19 pandemic impacting the global NGS sample preparation ecosystem?
•    What are the key development strategies that are being implemented by the major players in order to sustain themselves in the competitive market?
•    What are the key regulatory implications in developed and developing regions pertaining to the use of NGS sample preparation products?
•    What are the potential entry barriers expected to be faced by the companies willing to enter a particular region? 
•    How is each segment of the market expected to grow during the forecast period 2021-2026, and what is the anticipated revenue to be generated by each of the segments? Following are the segments:
        o    Product (Consumables, Standalone Automation Instruments, Automated Workstation, Accessories and Components)
        o    Workflow (Library Preparation, Target Enrichment, Sample Extraction/Isolation, Fragmentation, Sample Quantification, Library Quantification, Quality Control (QC), and Pooling)
        o    Application (DNA Sequencing, Whole Genome Sequencing, RNA Sequencing, Methylation Sequencing, and Others)
        o    Therapeutic Area (Oncology, Infectious Diseases, Human Genetics/Population Genetics, and Others)
        o    End User (Hospitals and Clinics, Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, and Others)
        o    Region (North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World)
•    What are the growth opportunities for the NGS sample preparation companies in the region of their operation?
•    Who are the leading players with significant offerings in the global NGS sample preparation market? 
•    Which companies are anticipated to be highly disruptive in the future, and why?

Report Summary

The global NGS sample preparation market is projected to reach $3,279.3 million by 2026.

The growth of the NGS sample preparation market is expected to be driven by the widespread use of NGS in diagnostic laboratories, which has enhanced the accuracy of genetic diagnostics with high consistency. Advanced genetic diagnostic techniques are being used for predictive genetic testing and prenatal diagnosis. As the number of people suffering from genetic disorders is increasing, the efficiency and consistency of the diagnostic screening tests are becoming more crucial. Faster results with minimum errors are required to effectively screen a genetic disorder. The automated NGS sample preparation enhances the consistency and throughput of sample preparation for genetic sequencing. The current market for NGS sample preparation is majorly dominated by manufacturers and service providers such as Thermo Fisher Scientific Inc, Illumina, Inc., BGI Group, Agilent Technologies, Inc., Aurora Biomed, Inc., F. Hoffmann-La Roche Ltd, OPENTRONS, Promega Corporation, Qiagen N.V.,  Bio-Rad Laboratories, Inc., Eppendorf AG, Oxford Nanopore Technologies plc., Tecan Trading AG , Hamilton Company, New England Biolabs (NEB), Danaher Corporation, and PerkinElmer, Inc.

The global NGS sample preparation market is projected to reach $3,279.3 million by 2026, growing from $1,468.9 million in 2020, at a CAGR of 14.24% during the forecast period 2021-2026.

Improvements in diagnostic methods for the diagnosis of genetic and chronic diseases are highly prioritized all across the globe. There are lots of advancements pertaining to the effective diagnosis of genetic diseases; however, there remains a lack of adoption of technologically advanced equipment in emerging economies. Most of the developing economies in the world still opt for manual instruments in the field of research and diagnostics on account of financial feasibility.

Competitive Landscape

The growth of the NGS sample preparation market can be majorly attributed to major manufacturers of NGS sample preparation products, along with the service providers, who are actively involved in undertaking significant business strategies to translate success in research and development into the commercial clinical setting. Enterprises, led by the market juggernauts, are frequently updating and developing their respective product and service portfolios with innovative solutions to sustain the high competition in the market. Additionally, competitors' activities also include several partnerships, collaborations, and joint ventures to expand individual product and service portfolios along with the global footprint. Based on region, North America holds the largest share in the market owing to the technological advancements in NGS sample preparation methods, improved healthcare infrastructure, rise in per capita income, and improvised reimbursement policies in the region. However, the Asia-Pacific region is anticipated to grow at the fastest CAGR during the forecast period 2021-2026.

Table of Contents

Download this TOC

Get Free Sample

1.1    Product Definition
1.2    The Basic NGS Workflow
         1.2.1    Global NGS Sample Preparation Market Scenario
         1.2.2    Inclusion and Exclusion
1.3    Market Scope
         1.3.1    Scope of the Study
         1.3.2    Key Questions Answered in the Report
1.4    Market Overview
         1.4.1    Market Definition
         1.4.2    Market Footprint and Growth Potential, $Million, 2020-2026
         1.4.3    Disruption in Global NGS Sample Preparation Market Due to COVID-19
         1.4.4    Navigating Crisis Recovery and Looking to the Future

2.1    Industry Insights
         2.1.1    Legal Requirements and Framework in the U.S.
         2.1.2    The U.S. FDA Published Guidance:
         2.1.3    The U.S. FDA Regulations
         2.1.4    Legal Requirements and Framework in Europe
         2.1.5    Legal Requirements and Framework in Asia-Pacific
                     2.1.5.1    China
                     2.1.5.2    Japan
                                    2.1.5.2.1    Pharmaceuticals and Medical Devices Agency (PMDA)
                                    2.1.5.2.2    Ministry of Health, Labour, and Welfare (MHLW)
                     2.1.5.3    India
2.2    Industry Trends
         2.2.1    Preference for Automated NGS Sample Preparation Workstations Integrated with Quality Control (QC)
         2.2.2    Growing Trend for the Preference of Customized Automated NGS Sample Preparation Platforms
2.3    Market Dynamics
         2.3.1    Impact Analysis
         2.3.2    Market Drivers
                     2.3.2.1    Increasing Use of NGS for Genetic Disorders
                     2.3.2.2    Technological Advancements in NGS Sample Preparation Methods
                     2.3.2.3    Rising Research Funding in the Field of Genomics
         2.3.3    Market Restraints
                     2.3.3.1    High Cost of Automated NGS Sample Preparation Instruments
                     2.3.3.2    Dearth of Skilled Professionals and Lack of Infrastructure in Emerging Countries
                     2.3.3.3    Stringent Regulatory Standards
         2.3.4    Market Opportunities
                     2.3.4.1    Adoption of Automated NGS Sample Preparation in the Emerging Markets
                     2.3.4.2    Rising Direct-to-Consumer Testing
        2.3.5    Opportunity (by Product)
                     2.3.5.1    Workstations
                     2.3.5.2    Consumables
         2.3.6    Opportunity (by Application)
                     2.3.6.1    DNA Sequencing
                     2.3.6.2    Metagenomics
         2.3.7    Opportunity (by Region)
                     2.3.7.1    North America
                     2.3.7.2    Asia-Pacific (APAC)

3.1    Overview
3.2    Synergistic Activities
3.3    Product Launches
3.4    Mergers and Acquisitions
3.5    Other Business Activities
3.6    Market Share Analysis, 2019-2020
3.7    Growth Share Analysis (Company)
3.8    Growth Share Analysis by End User
3.9    Growth Share Analysis by Region

4.1    Overview
4.2    Consumables
         4.2.1    Sample Extraction and Isolation Kits
         4.2.2    Sample Purification Kits
         4.2.3    Library Preparation Kits
                     4.2.3.1    DNA Library Preparation Kits
                     4.2.3.2    RNA Library Preparation Kits
                     4.2.3.3    Library Quantification
                     4.2.3.4    Library Amplification
                     4.2.3.5    FFPE DNA Kits
                     4.2.3.6    ChIP-Seq Library Preparation
                     4.2.3.7    Library Preparation Accessories
         4.2.4    Target Enrichment
         4.2.5    Cleanup and Selection Kits
         4.2.6    Microbiome DNA Enrichment
         4.2.7    Other Consumables
4.3    Automated Workstation
         4.3.1    Open System
         4.3.2    Close System
4.4    Standalone Automation Instruments
         4.4.1    Fragment Analyzer
         4.4.2    Nucleic Acid Extraction/Isolation System
         4.4.3    DNA Selection Instrument
         4.4.4    DNA/RNA Shearing Instruments
         4.4.5    Template Preparation Instruments
         4.4.6    Ultrasonicator/Sonicator
4.5    Accessories and Components

5.1    Overview
5.2    Library Preparation
5.3    Target Enrichment
5.4    Sample Extraction/Isolation
5.5    Fragmentation
5.6    Sample Quantification
5.7    Library Quantification
5.8    Quality Control (QC)
5.9    Pooling

6.1    Overview
6.2    Oncology
6.3    Infectious Diseases
6.4    Human Genetics/Population Genetics
6.5    Others

7.1    Overview
7.2    DNA Sequencing
7.3    Whole Genome Sequencing
7.4    RNA Sequencing
7.5    Methylation Sequencing
7.6    Other Applications

8.1    Overview
8.2    Hospitals and Clinics
8.3    Academic and Research Institutions
8.4    Pharmaceutical and Biotechnology Companies
8.5    Other End Users

9.1    Overview
9.2    North America
         9.2.1    U.S.
         9.2.2    Canada
9.3    Europe
         9.3.1    Germany
         9.3.2    France
         9.3.3    U.K.
         9.3.4    Italy
         9.3.5    Spain
         9.3.6    Netherlands
         9.3.7    Denmark
         9.3.8    Switzerland
         9.3.9    Belgium
         9.3.10    Rest-of-Europe
9.4    Asia-Pacific
         9.4.1    China
         9.4.2    Japan
         9.4.3    Australia
         9.4.4    India
         9.4.5    South Korea
         9.4.6    Singapore
         9.4.7    Rest-of-Asia-Pacific
9.5    Latin America (LATAM)
         9.5.1    Brazil
         9.5.2    Mexico
         9.5.3    Rest-of-Latin America
9.6    Rest-of-the-World (RoW)

10.1    Overview
10.2    Agilent Technologies, Inc.
          10.2.1    Company Overview
          10.2.2    Role of Agilent Technologies, Inc. in the Global NGS Sample Preparation Market
          10.2.3    Financials
          10.2.4    Key Insights About Financial Health of the Company
          10.2.5    SWOT Analysis
10.3    Aurora Biomed Inc.
          10.3.1    Company Overview
          10.3.2    Role of Aurora Biomed Inc. in the Global NGS Sample Preparation Market
          10.3.3    SWOT Analysis
10.4    Danaher
          10.4.1    Company Overview
          10.4.2    Role of Danaher in the Global NGS Sample Preparation Market
          10.4.3    Financials
          10.4.4    Key Insights About Financial Health of the Company
          10.4.5    SWOT Analysis
10.5    Bio-Rad Laboratories, Inc.
          10.5.1    Company Overview
          10.5.2    Role of Bio-Rad Laboratories, Inc. in the Global NGS Sample Preparation market
          10.5.3    Financials
          10.5.4    Key Insights About Financial Health of the Company
          10.5.5    SWOT Analysis
10.6    Eppendorf SE
          10.6.1    Company Overview
          10.6.2    Role of Eppendorf SE in the NGS Sample Preparation Market
          10.6.3    Financials
          10.6.4    Key Insights About Financial Health of the Company
          10.6.5    SWOT Analysis
10.7    Opentrons
          10.7.1    Company Overview
          10.7.2    Role of Opentrons in the Global NGS Sample Preparation Market
          10.7.3    SWOT Analysis
10.8    BGI Group
          10.8.1    Company Overview
          10.8.2    Role of BGI Group in the Global NGS Sample Preparation Market
          10.8.3    SWOT Analysis
10.9    Promega Corporation
          10.9.1    Company Overview
          10.9.2    Role of Promega Corporation in the Global NGS Sample Preparation Market
          10.9.3    SWOT Analysis
10.10    Oxford Nanopore Technologies plc.
             10.10.1    Company Overview
             10.10.2    Role of Oxford Nanopore Technologies plc. In the Global NGS Sample Preparation Market
             10.10.3    Financials
             10.10.4    Key Insights About Financial Health of the Company
             10.10.5    SWOT Analysis
10.11    F. Hoffmann-La Roche Ltd
             10.11.1    Company Overview
             10.11.2    Role of F. Hoffmann-La Roche Ltd in the Global NGS Sample Preparation Market
             10.11.3    Financials
             10.11.4    Key Insights About Financial Health of the Company
             10.11.5    SWOT Analysis
10.12    Tecan Trading AG
             10.12.1    Company Overview
             10.12.2    Role of Tecan Trading AG in the Global NGS Sample Preparation Market
             10.12.3    Financials
             10.12.4    Key Insights About Financial Health of the Company
             10.12.5    SWOT Analysis
10.13    Hamilton Company
             10.13.1    Company Overview
             10.13.2    Role of Hamilton Company in the Global NGS Sample Preparation Market
             10.13.3    SWOT Analysis
10.14    PerkinElmer Inc.
             10.14.1    Company Overview
             10.14.2    Role of PerkinElmer Inc. in the Global NGS Sample Preparation Market
             10.14.3    Financials
             10.14.4    Key Insights About Financial Health of the Company
             10.14.5    SWOT Analysis
10.15    Illumina, Inc.
             10.15.1    Company Overview
             10.15.2    Role of Illumina, Inc. in the Global NGS Sample Preparation Market
             10.15.3    Financials
             10.15.4    Key Insights About Financial Health of the Company
             10.15.5    SWOT Analysis
10.16    Thermo Fisher Scientific Inc.
             10.16.1    Company Overview
             10.16.2    Role of Thermo Fisher Scientific Inc. in the Global NGS Sample Preparation Market
             10.16.3    Financials
             10.16.4    Key Insights About Financial Health of the Company
             10.16.5    SWOT Analysis
10.17    New England Biolabs.
             10.17.1    Company Overview
             10.17.2    Role of New England Biolabs. in the Global Next-Generation Sequencing Sample Preparation Market
             10.17.3    SWOT Analysis
10.18    QIAGEN
             10.18.1    Company Overview
             10.18.2    Role of QIAGEN in the Global NGS Sample Preparation Market
             10.18.3    Financials
             10.18.4    Key Insights About Financial Health of the Company
             10.18.5    SWOT Analysis
10.19    Pacific Biosciences of California, Inc.
             10.19.1    Company Overview
             10.19.2    Role of Pacific Biosciences of California, Inc. in the Global NGS Sample Preparation Market
             10.19.3    Financials
             10.19.4    Key Insights About Financial Health of the Company
             10.19.5    SWOT Analysis

Table 1:    Impact Analysis of Market Drivers and Market Challenges in the Global NGS Sample Preparation Market
Table 2:    Approved Next-Generation Sequencing (NGS) Panels in Japan
Table 3:    Cost of NGS Per Sample on Different Applications
Table 4:    Companies Providing Sample Extraction and Isolation Kits
Table 5:    Companies Providing Library Preparation Kits
Table 6:    Companies Providing Target Enrichment Kits
Table 7:    Companies Offering Automated Workstation
Table 8:    Companies Offering Standalone Automation Instruments
Table 9:    Companies and their Therapeutic Areas for NGS Sample Preparation
Table 10:    Companies and their Application in NGS Sample Preparation

Figure 1:    Global Cancer Burden, 2020
Figure 2:    Distribution of Deaths Due to People Suffering from Cystic Fibrosis (CF), 2019
Figure 3:    Global NGS Sample Preparation Market (by Product), $Million, 2020 and 2026
Figure 4:    Global NGS Sample Preparation Market (by Workflow), $Million, 2020 and 2026
Figure 5:    Global NGS Sample Preparation Market (by Application), $Million, 2020 and 2026
Figure 6:    Global NGS Sample Preparation Market (by Therapeutic Area), $Million, 2020 and 2026
Figure 7:    Global NGS Sample Preparation Market (by End User), $Million, 2020 and 2026
Figure 8:    Global NGS Sample Preparation Market Snapshot
Figure 9:    Global NGS Sample Preparation Market: Research Methodology
Figure 10:    Primary Research Methodology
Figure 11:    Bottom-Up Approach (Segment-Wise Analysis)
Figure 12:    Top-Down Approach (Segment-Wise Analysis)
Figure 13:    Global NGS Sample Preparation Market, 2020-2026
Figure 14:    Global NGS Sample Preparation Market Segmentation
Figure 15:    Global NGS Sample Preparation Market, $Million, 2020-2026
Figure 16:    Global NGS Sample Preparation Market: COVID-19 Impact Analysis
Figure 17:    FDA’s Regulatory Insight System
Figure 18:    Global NGS Sample Preparation Market Dynamics
Figure 19:    Deaths Due to Cystic Fibrosis (CF), 2019
Figure 20:    China Healthcare Expenditure (% of GDP), 2010-2018
Figure 21:    Share of Key Developments and Strategies, January 2018-November 2021
Figure 22:    Share of Synergistic Activities (by Company), January 2018-November 2021
Figure 23:    Number of Product Launches (by Company), January 2018-November 2021
Figure 24:    Share of Mergers and Acquisitions (by Company), January 2018–November 2021
Figure 25:    Market Share Analysis for Global NGS Sample Preparation Market, $Million, 2019 and 2020
Figure 26:    Growth Share Analysis for Global NGS Sample Preparation Market (by Company), 2020
Figure 27:    Growth Share Matrix for Global NGS Sample Preparation Market (by End User), 2020
Figure 28:    Growth Share Matrix for Global NGS Sample Preparation Market (by Region), 2020
Figure 29:    Global NGS Sample Preparation Market (by Product)
Figure 30:    Global NGS Sample Preparation Market (by Product), $Million, 2020 and 2026
Figure 31:    Global NGS Sample Preparation Market (by Consumables), $Million, 2020-2026
Figure 32:    Global NGS Sample Preparation Market (Sample Extraction and Isolation Kits), $Million, 2020-2026
Figure 33:    Global NGS Sample Preparation Market (Sample Purification Kits), $Million, 2020-2026
Figure 34:    Global NGS Sample Preparation Market (Library Preparation Kits), $Million, 2020-2026
Figure 35:    Global NGS Sample Preparation Market (DNA Library Preparation Kits), $Million, 2020-2026
Figure 36:    Global NGS Sample Preparation Market (RNA Library Preparation Kits), $Million, 2020-2026
Figure 37:    Global NGS Sample Preparation Market (Library Quantification), $Million, 2020-2026
Figure 38:    Global NGS Sample Preparation Market (Library Amplification), $Million, 2020-2026
Figure 39:    Global NGS Sample Preparation Market (FFPE DNA Kits), $Million, 2020-2026
Figure 40:    Global NGS Sample Preparation Market (ChIP-Seq Library Preparation), $Million, 2020-2026
Figure 41:    Global NGS Sample Preparation Market (Library Preparation Accessories), $Million, 2020-2026
Figure 42:    Global NGS Sample Preparation Market (Target Enrichment), $Million, 2020-2026
Figure 43:    Global NGS Sample Preparation Market (Cleanup and Selection Kits), $Million, 2020-2026
Figure 44:    Global NGS Sample Preparation Market (Microbiome DNA Enrichment), $Million, 2020-2026
Figure 45:    Global NGS Sample Preparation Market (Other Consumables), $Million, 2020-2026
Figure 46:    Global NGS Sample Preparation Market (by Automated Workstation), $Million, 2020-2026
Figure 47:    Global NGS Sample Preparation Market (Open System), $Million, 2020-2026
Figure 48:    Global NGS Sample Preparation Market (Close System), $Million, 2020-2026
Figure 49:    Global NGS Sample Preparation Market (by Standalone Automation Instruments), $Million, 2020-2026
Figure 50:    Global NGS Sample Preparation Market (Fragment Analyzer), $Million, 2020-2026
Figure 51:    Global NGS Sample Preparation Market (Nucleic Acid Extraction/Isolation System), $Million, 2020-2026
Figure 52:    Global NGS Sample Preparation Market (DNA Selection Instrument), $Million, 2020-2026
Figure 53:    Global NGS Sample Preparation Market (DNA/RNA Shearing Instruments), $Million, 2020-2026
Figure 54:    Global NGS Sample Preparation Market (Template Preparation Instruments), $Million, 2020-2026
Figure 55:    Global NGS Sample Preparation Market (Ultrasonicator/Sonicator), $Million, 2020-2026
Figure 56:    Global NGS Sample Preparation Accessories and Components Market, $Million, 2020-2026
Figure 57:    Global NGS Sample Preparation Market (Workflow)
Figure 58:    Global NGS Sample Preparation Market (Library Preparation), $Million, 2020-2026
Figure 59:    Global NGS Sample Preparation Market (Target Enrichment), $Million, 2020-2026
Figure 60:    Global NGS Sample Preparation Market (Sample Extraction/Isolation), $Million, 2020-2026
Figure 61:    Global NGS Sample Preparation Market (Fragmentation), $Million, 2020-2026
Figure 62:    Global NGS Sample Preparation Market (Sample Quantification), $Million, 2020-2026
Figure 63:    Global NGS Sample Preparation Market (Library Quantification), $Million, 2020-2026
Figure 64:    Global NGS Sample Preparation Market (Quality Control (QC)), $Million, 2020-2026
Figure 65:    Global NGS Sample Preparation Market (Pooling), $Million, 2020-2026
Figure 66:    Share of Global NGS Sample Preparation Market (by Therapeutic Area), $Million 2020 and 2026
Figure 67:    Global NGS Sample Preparation Market (Oncology), $Million, 2020-2026
Figure 68:    Global NGS Sample Preparation Market (Infectious Diseases), $Million, 2020-2026
Figure 69:    Global NGS Sample Preparation Market (Human Genetics/Population Genetics), $Million, 2020-2026
Figure 70:    Global NGS Sample Preparation Market (Others), $Million, 2020-2026
Figure 71:    Share of Global NGS Sample Preparation Market (by Application), $Million, 2020 and 2026
Figure 72:    Global NGS Sample Preparation Market (DNA Sequencing), $Million, 2020-2026
Figure 73:    Global NGS Sample Preparation Market (Whole Genome Sequencing), $Million, 2020-2026
Figure 74:    Global NGS Sample Preparation Market (RNA Sequencing), $Million, 2020-2026
Figure 75:    Global NGS Sample Preparation Market (Methylation Sequencing), $Million, 2020-2026
Figure 76:    Global NGS Sample Preparation Market (Other Applications), $Million, 2020-2026
Figure 77:    Global NGS Sample Preparation Market (by End User), $Million, 2020- 2026
Figure 78:    Global NGS Sample Preparation Market (Hospitals and Clinics), $Million, 2020-2026
Figure 79:    Global NGS Sample Preparation Market (Academic and Research Institutions), $Million, 2020-2026
Figure 80:    Global NGS Sample Preparation Market (Pharmaceutical and Biotechnology Companies), $Million, 2020-2026
Figure 81:    Global NGS Sample Preparation Market (Other End Users), $Million, 2020-2026
Figure 82:    Global NGS Sample Preparation Market (by Region), $Million, 2021-2026
Figure 83:    Share of North America NGS Sample Preparation Market Revenue (by Country), $Million, 2020 and 2026
Figure 84:    North America: Market Dynamics
Figure 85:    North America NGS Sample Preparation Market (by Country), $Million,  2020-2026
Figure 86:    U.S. NGS Sample Preparation Market, $Million, 2020-2026
Figure 87:    U.S. NGS Sample Preparation Market (by Product), $Million, 2020-2026
Figure 88:    U.S. NGS Sample Preparation Market, (by Automated Workstation), $Million, 2020-2026
Figure 89:    U.S. NGS Sample Preparation Market, (by Standalone Automation Instruments), $Million, 2020-2026
Figure 90:    U.S. NGS Sample Preparation Market, (by Consumables), $Million, 2020-2026
Figure 91:    Canada NGS Sample Preparation Market, $Million, 2020-2026
Figure 92:    Canada NGS Sample Preparation Market (by Product), $Million, 2020-2026
Figure 93:    Canada NGS Sample Preparation Market (by Automated Workstation), $Million, 2020-2026
Figure 94:    Canada NGS Sample Preparation Market (by Standalone Automation Instruments), $Million, 2020-2026
Figure 95:    Canada NGS Sample Preparation Market (by Consumables), $Million, 2020-2026
Figure 96:    Europe NGS Sample Preparation Market (by Country), $Million, 2020 and 2026
Figure 97:    Europe: Market Dynamics
Figure 98:    Europe NGS Sample Preparation Market (by Country), $Million, 2020-2026
Figure 99:    Germany NGS Sample Preparation Market, $Million, 2020-2026
Figure 100:    Germany NGS Sample Preparation Market (by Product), $Million, 2020-2026
Figure 101:    Germany NGS Sample Preparation Market (by Automated Workstation), $Million, 2020-2026
Figure 102:    Germany NGS Sample Preparation Market (by Standalone Automation Instruments), $Million, 2020-2026
Figure 103:    Germany NGS Sample Preparation Market (by Consumables), $Million, 2020-2026
Figure 104:    France NGS Sample Preparation Market, $Million, 2020-2026
Figure 105:    France NGS Sample Preparation Market (by Product), $Million, 2020-2026
Figure 106:    France NGS Sample Preparation Market (by Automated Workstation), $Million, 2020-2026
Figure 107:    France NGS Sample Preparation Market (by Standalone Automation Instruments), $Million, 2020-2026
Figure 108:    France NGS Sample Preparation Market (by Consumables), $Million, 2020-2026
Figure 109:    U.K. NGS Sample Preparation Market, $Million, 2020-2026
Figure 110:    U.K. NGS Sample Preparation Market (by Product), $Million, 2020-2026
Figure 111:    U.K. NGS Sample Preparation Market (by Automated Workstation), $Million, 2020-2026
Figure 112:    U.K. NGS Sample Preparation Market (by Standalone Automation Instruments), $Million, 2020-2026
Figure 113:    U.K. NGS Sample Preparation Market (by Consumables), $Million, 2020-2026
Figure 114:    Italy NGS Sample Preparation Market, $Million, 2020-2026
Figure 115:    Italy NGS Sample Preparation Market (by Product), $Million, 2020-2026
Figure 116:    Italy NGS Sample Preparation Market (by Automated Workstation), $Million, 2020-2026
Figure 117:    Italy NGS Sample Preparation Market (by Standalone Automation Instruments), $Million, 2020-2026
Figure 118:    Italy NGS Sample Preparation Market (by Consumables), $Million, 2020-2026
Figure 119:    Spain NGS Sample Preparation Market, $Million, 2020-2026
Figure 120:    Spain NGS Sample Preparation Market (by Product), $Million, 2020-2026
Figure 121:    Spain NGS Sample Preparation Market (by Automated Workstation), $Million, 2020-2026
Figure 122:    Spain NGS Sample Preparation Market (by Standalone Automation Instruments), $Million, 2020-2026
Figure 123:    Spain NGS Sample Preparation Market (by Consumables), $Million, 2020-2026
Figure 124:    Netherlands NGS Sample Preparation Market, $Million, 2020-2026
Figure 125:    Denmark NGS Sample Preparation Market, $Million, 2020-2026
Figure 126:    Switzerland NGS Sample Preparation Market, $Million, 2020-2026
Figure 127:    Belgium NGS Sample Preparation Market, $Million, 2020-2026
Figure 128:    Rest-of-Europe NGS Sample Preparation Market, $Million, 2020-2026
Figure 129:    Rest-of-Europe NGS Sample Preparation Market (by Product), $Million, 2020-2026
Figure 130:    Rest-of-Europe NGS Sample Preparation Market (by Automated Workstation), $Million, 2020-2026
Figure 131:    Rest-of-Europe NGS Sample Preparation Market (by Standalone Automation Instruments), $Million, 2020-2026
Figure 132:    Rest-of-Europe NGS Sample Preparation Market (by Consumables), $Million, 2020-2026
Figure 133:    APAC: Market Dynamics
Figure 134:    Asia-Pacific NGS Sample Preparation Market (by Country), $Million, 2020 and 2026
Figure 135:    China NGS Sample Preparation Market, $Million, 2020-2026
Figure 136:    China NGS Sample Preparation Market (by Product), $Million, 2020-2026
Figure 137:    China NGS Sample Preparation Market (by Automated Workstation), $Million, 2020-2026
Figure 138:    China NGS Sample Preparation Market (by Standalone Automation Instruments), $Million, 2020-2026
Figure 139:    China NGS Sample Preparation Market (by Consumables), $Million, 2020-2026
Figure 140:    Japan NGS Sample Preparation Market, $Million, 2020-2026
Figure 141:    Japan NGS Sample Preparation Market (by Product), $Million, 2020-2026
Figure 142:    Japan NGS Sample Preparation Market (by Automated Workstation), $Million, 2020-2026
Figure 143:    Japan NGS Sample Preparation Market (by Standalone Automation Instruments), $Million, 2020-2026
Figure 144:    Japan NGS Sample Preparation Market (by Consumables), $Million, 2020-2026
Figure 145:    Australia NGS Sample Preparation Market, $Million, 2020-2026
Figure 146:    Australia NGS Sample Preparation Market (by Product), $Million, 2020-2026
Figure 147:    Australia NGS Sample Preparation Market (by Automated Workstation), $Million, 2020-2026
Figure 148:    Australia NGS Sample Preparation Market (by Standalone Automation Instruments), $Million, 2020-2026
Figure 149:    Australia NGS Sample Preparation Market (by Consumables), $Million, 2020-2026
Figure 150:    India NGS Sample Preparation Market, $Million, 2020-2026
Figure 151:    India NGS Sample Preparation Market (by Product), $Million, 2020-2026
Figure 152:    India NGS Sample Preparation Market (by Automated Workstation), $Million, 2020-2026
Figure 153:    India NGS Sample Preparation Market (by Standalone Automation Instruments), $Million, 2020-2026
Figure 154:    India NGS Sample Preparation Market (by Consumables), $Million, 2020-2026
Figure 155:    South Korea NGS Sample Preparation Market, $Million, 2020-2026
Figure 156:    South Korea NGS Sample Preparation Market (by Product), $Million, 2020-2026
Figure 157:    South Korea NGS Sample Preparation Market (by Automated Workstation), $Million, 2020-2026
Figure 158:    South Korea NGS Sample Preparation Market (by Standalone Automation Instruments), $Million, 2020-2026
Figure 159:    South Korea NGS Sample Preparation Market (by Consumables), $Million, 2020-2026
Figure 160:    Singapore NGS Sample Preparation Market, $Million, 2020-2026
Figure 161:    Singapore NGS Sample Preparation Market (by Product), $Million, 2020-2026
Figure 162:    Singapore NGS Sample Preparation Market (by Automated Workstation), $Million, 2020-2026
Figure 163:    Singapore NGS Sample Preparation Market (by Standalone Automation Instruments), $Million, 2020-2026
Figure 164:    Singapore NGS Sample Preparation Market (by Consumables), $Million, 2020-2026
Figure 165:    Rest-of-Asia-Pacific NGS Sample Preparation Market, $Million, 2020-2026
Figure 166:    Rest-of-Asia-Pacific NGS Sample Preparation Market (by Product), $Million, 2020-2026
Figure 167:    Rest-of-Asia-Pacific NGS Sample Preparation Market (by Automated Workstation), $Million, 2020-2026
Figure 168:    Rest-of-Asia-Pacific NGS Sample Preparation Market (by Standalone Automation Instruments), $Million, 2020-2026
Figure 169:    Rest-of-Asia-Pacific NGS Sample Preparation Market (by Consumables), $Million, 2020-2026
Figure 170:    LATAM: Market Dynamics
Figure 171:    Latin America NGS Sample Preparation Market (by Country), $Million 2020 and2026
Figure 172:    Brazil NGS Sample Preparation Market, $Million, 2020-2026
Figure 173:    Brazil NGS Sample Preparation Market (by Product), $Million, 2020-2026
Figure 174:    Brazil NGS Sample Preparation Market (by Automated Workstation), $Million, 2020-2026
Figure 175:    Brazil NGS Sample Preparation Market (by Standalone Automation Instruments), $Million, 2020-2026
Figure 176:    Brazil NGS Sample Preparation Market (by Consumables), $Million, 2020-2026
Figure 177:    Mexico NGS Sample Preparation Market, $Million, 2020-2026
Figure 178:    Mexico NGS Sample Preparation Market (by Product), $Million, 2020-2026
Figure 179:    Mexico NGS Sample Preparation Market (by Automated Workstation), $Million, 2020-2026
Figure 180:    Mexico NGS Sample Preparation Market (by Standalone Automation Instruments), $Million, 2020-2026
Figure 181:    Mexico NGS Sample Preparation Market (by Consumables), $Million, 2020-2026
Figure 182:    Rest-of-Latin America NGS Sample Preparation Market, $Million, 2020-2026
Figure 183:    Rest-of-Latin America NGS Sample Preparation Market (by Product), $Million, 2020-2026
Figure 184:    Rest-of-Latin America NGS Sample Preparation Market (by Automated Workstation), $Million, 2020-2026
Figure 185:    Rest-of-Latin America NGS Sample Preparation Market (by Standalone Automation Instruments), $Million, 2020-2026
Figure 186:    Rest-of-Latin America NGS Sample Preparation Market (by Consumables), $Million, 2020-2026
Figure 187:    Rest-of-the-World NGS Sample Preparation Market, $Million, 2020-2026
Figure 188:    Total Number of Companies Profiled
Figure 189:    Agilent Technologies, Inc.: Product Portfolio
Figure 190:    Agilent Technologies, Inc.: Overall Financials, 2018-2020
Figure 191:    Agilent Technologies, Inc.: Revenue (by Segment), 2018-2020
Figure 192:    Agilent Technologies, Inc.: Revenue (by Region), 2018-2020
Figure 193:    Agilent Technologies, Inc.: R&D Expenditure, 2018-2020
Figure 194:    Agilent Technologies, Inc.: SWOT Analysis
Figure 195:    Aurora Biomed Inc.: Overall Product Portfolio
Figure 196:    Aurora Biomed Inc.: SWOT Analysis
Figure 197:    Danaher: Product Portfolio
Figure 198:    Danaher: Overall Financials, 2018-2020
Figure 199:    Danaher: Revenue (by Business Segment), 2018-2020
Figure 200:    Danaher: Revenue (by Region), 2018-2020
Figure 201:    Danaher: R&D Expenditure, 2018-2020
Figure 202:    Danaher Corporation: SWOT Analysis
Figure 203:    Bio-Rad Laboratories, Inc.: Product Portfolio
Figure 204:    Bio-Rad Laboratories, Inc.: Overall Financials, $Million, 2018-2020
Figure 205:    Bio-Rad Laboratories, Inc.: Revenue (by Segment), $Million, 2018-2020
Figure 206:    Bio-Rad Laboratories, Inc.: Revenue (by Region), $Million, 2018-2020
Figure 207:    Bio-Rad Laboratories, Inc.: R&D Expenditure, $Million, 2018-2020
Figure 208:    Bio-Rad Laboratories, Inc.: SWOT Analysis
Figure 209:    Eppendorf SE: Overall Product Portfolio
Figure 210:    Eppendorf SE: Overall Financials, 2018-2020
Figure 211:    Eppendorf SE: Revenue (by Region), 2018-2020
Figure 212:    Eppendorf AG: R&D Expenditure, 2018-2020
Figure 213:    Eppendorf SE: SWOT Analysis
Figure 214:    Opentrons.: Product Offerings
Figure 215:    Opentrons: SWOT Analysis
Figure 216:    BGI Group: Product Portfolio
Figure 217:    BGI Group: SWOT Analysis
Figure 218:    Promega Corporation: Product Portfolio
Figure 219:    Promega Corporation: SWOT Analysis
Figure 220:    Oxford Nanopore Technologies plc.: Product Offerings
Figure 221:    Oxford Nanopore Technologies plc: Overall Financials, $Million, 2018-2020
Figure 222:    Oxford Nanopore Technologies plc: Revenue (by Segment), $Million, 2018-2020
Figure 223:    Oxford Nanopore Technologies plc: Revenue (by Region), $Million, 2018-2020
Figure 224:    Oxford Nanopore Technologies plc.: R&D Expenditure, $Million, 2018-2020
Figure 225:    Oxford Nanopore Technologies plc: SWOT Analysis
Figure 226:    F. Hoffmann-La Roche Ltd: Product Portfolio
Figure 227:    F. Hoffmann-La Roche Ltd: Overall Financials, 2018-2020
Figure 228:    F. Hoffmann-La Roche Ltd: Revenue (by Segment), 2018-2020
Figure 229:    F. Hoffmann-La Roche Ltd: Revenue (by Region), 2018-2020
Figure 230:    F. Hoffmann La-Roche Ltd.: R&D Expenditure, 2018-2020
Figure 231:    F. Hoffmann-La Roche Ltd: SWOT Analysis
Figure 232:    Product Portfolio: Tecan Trading AG
Figure 233:    Tecan Trading AG: Overall Financials, 2018-2020
Figure 234:    Tecan Trading AG: R&D Expenditure, 2018-2020
Figure 235:    Tecan Trading AG: SWOT Analysis
Figure 236:    Hamilton Company: Overall Product Portfolio
Figure 237:    Hamilton Company: SWOT Analysis
Figure 238:    PerkinElmer Inc.: Product Portfolio
Figure 239:    PerkinElmer Inc.: Overall Financials, (2018-2020)
Figure 240:    PerkinElmer Inc.: Revenue (by Business Segment), 2018-2020
Figure 241:    PerkinElmer, Inc.: Revenue (by Region), 2018-2020
Figure 242:    PerkinElmer, Inc.: R&D Expenditure, 2018-2020
Figure 243:    PerkinElmer, Inc.: SWOT Analysis
Figure 244:    Illumina, Inc. Product Portfolio
Figure 245:    Illumina, Inc. Overall Financials, 2018-2020
Figure 246:    Illumina, Inc. Revenue (by Segment), 2018-2020
Figure 247:    Illumina, Inc. Revenue (by Region), 2018-2020
Figure 248:    Illumina Inc.: R&D Expenditure, 2018-2020
Figure 249:    Illumina, Inc.: SWOT Analysis
Figure 250:    Thermo Fisher Scientific Inc.: Product Portfolio
Figure 251:    Thermo Fisher Scientific Inc.: Overall Financials, 2018-2020
Figure 252:    Thermo Fisher Scientific Inc.: Revenue (by Geographical Region), 2018-2020
Figure 253:    Thermo Fisher Scientific Inc.: R&D Expenditure, 2018-2020
Figure 254:    Thermo Fisher Scientific Inc.: SWOT Analysis
Figure 255:    New England Biolabs.: Product Portfolio
Figure 256:    New England Biolabs.: SWOT Analysis
Figure 257:    QIAGEN: Product Portfolio
Figure 258:    QIAGEN: Overall Financials, 2018-2020
Figure 259:    QIAGEN: Revenue (by Segment), 2018-2020
Figure 260:    QIAGEN: Revenue (by Region), 2018-2020
Figure 261:    QIAGEN: R&D Expenditure, 2018-2020
Figure 262:    QIAGEN: SWOT Analysis
Figure 263:    Pacific Biosciences of California, Inc.: Product Portfolio
Figure 264:    Pacific Biosciences of California, Inc.: Overall Financials, $Million, 2018-2020
Figure 265:    Pacific Biosciences of California, Inc.: Revenue (by Segment), $Million, 2018-2020
Figure 266:    Pacific Biosciences of California, Inc.: Revenue (by Region), $Million, 2018-2020
Figure 267:    Pacific Biosciences of California, Inc.: R&D Expenditure, $Million, 2018-2020
Figure 268:    Pacific Biosciences of California, Inc.: SWOT Analysis

Market Report Coverage

NGS Sample Preparation Market

Base Year

2020

Market Size in 2021

$1,685.6 Million

Forecast Period

2021-2026

Value Projection and Estimation by 2026

$3,279.3 Million

CAGR During Forecast Period

14.24%

Number of Tables

10

Number of Pages

294

Number of Figures

268

Market Segmentation

•    Product (Consumables, Standalone Automation Instruments, Automated Workstation, Accessories and Components)

•    Workflow (Library Preparation, Target Enrichment, Sample Extraction/Isolation, Fragmentation, Sample Quantification, Library Quantification, Quality Control (QC), and Pooling)

•    Therapeutic Area (Oncology, Infectious Diseases, Human Genetics/Population Genetics, and Others)

•    Application (DNA Sequencing, Whole Genome Sequencing, RNA Sequencing, Methylation Sequencing, and Others)

•    End User (Hospitals and Clinics, Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, and Others)

Regional Segmentation

•    North America: U.S., Canada

•    Europe: Germany, France, U.K., Italy, Spain, Netherlands, Denmark, Belgium, Switzerland, and Rest-of-Europe

•    Asia-Pacific: China, Japan, India, South Korea, Australia, Singapore, and Rest-of-Asia-Pacific

•    Latin America: Brazil, Mexico, and Rest-of-Latin America

•    Rest-of-the-World

Market Growth Drivers

•    Increasing Use of NGS for Genetic Disorders

•    Technological Advancements in NGS Sample Preparation Methods

•    Rising Research Funding in the Field of Genomics

Market Challenges

•    High Cost of Automated NGS Sample Preparation Instruments

•    Dearth of Skilled Professionals and Lack of Infrastructure in Emerging Countries

•    Stringent Regulatory Standards

Market Opportunities

•    Adoption of Automated NGS Sample Preparation in the Emerging Markets

•    Rising Direct-to-Consumer Testing

Key Companies Profiled

Agilent Technologies, Inc., Aurora Biomed Inc., Danaher, Bio-Rad Laboratories, Inc., Eppendorf SE, Opentrons, BGI Group, Promega Corporation, Oxford Nanopore Technologies plc., F. Hoffmann-La Roche Ltd, Tecan Trading AG, Hamilton Company, PerkinElmer Inc., Illumina, Inc., Thermo Fisher Scientific Inc., New England Biolabs, QIAGEN, Pacific Biosciences of California, Inc.

Key Questions Answered in this Report:

•    How is NGS sample preparation revolutionizing oncology?
•    What are the major market drivers, challenges, and opportunities in the global NGS sample preparation market?
•    What are the underlying structures resulting in the emerging trends within the global NGS sample preparation market?
•    How is the COVID-19 pandemic impacting the global NGS sample preparation ecosystem?
•    What are the key development strategies that are being implemented by the major players in order to sustain themselves in the competitive market?
•    What are the key regulatory implications in developed and developing regions pertaining to the use of NGS sample preparation products?
•    What are the potential entry barriers expected to be faced by the companies willing to enter a particular region? 
•    How is each segment of the market expected to grow during the forecast period 2021-2026, and what is the anticipated revenue to be generated by each of the segments? Following are the segments:
        o    Product (Consumables, Standalone Automation Instruments, Automated Workstation, Accessories and Components)
        o    Workflow (Library Preparation, Target Enrichment, Sample Extraction/Isolation, Fragmentation, Sample Quantification, Library Quantification, Quality Control (QC), and Pooling)
        o    Application (DNA Sequencing, Whole Genome Sequencing, RNA Sequencing, Methylation Sequencing, and Others)
        o    Therapeutic Area (Oncology, Infectious Diseases, Human Genetics/Population Genetics, and Others)
        o    End User (Hospitals and Clinics, Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, and Others)
        o    Region (North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World)
•    What are the growth opportunities for the NGS sample preparation companies in the region of their operation?
•    Who are the leading players with significant offerings in the global NGS sample preparation market? 
•    Which companies are anticipated to be highly disruptive in the future, and why?

Report Summary

The growth of the NGS sample preparation market is expected to be driven by the widespread use of NGS in diagnostic laboratories, which has enhanced the accuracy of genetic diagnostics with high consistency. Advanced genetic diagnostic techniques are being used for predictive genetic testing and prenatal diagnosis. As the number of people suffering from genetic disorders is increasing, the efficiency and consistency of the diagnostic screening tests are becoming more crucial. Faster results with minimum errors are required to effectively screen a genetic disorder. The automated NGS sample preparation enhances the consistency and throughput of sample preparation for genetic sequencing. The current market for NGS sample preparation is majorly dominated by manufacturers and service providers such as Thermo Fisher Scientific Inc, Illumina, Inc., BGI Group, Agilent Technologies, Inc., Aurora Biomed, Inc., F. Hoffmann-La Roche Ltd, OPENTRONS, Promega Corporation, Qiagen N.V.,  Bio-Rad Laboratories, Inc., Eppendorf AG, Oxford Nanopore Technologies plc., Tecan Trading AG , Hamilton Company, New England Biolabs (NEB), Danaher Corporation, and PerkinElmer, Inc.

The global NGS sample preparation market is projected to reach $3,279.3 million by 2026, growing from $1,468.9 million in 2020, at a CAGR of 14.24% during the forecast period 2021-2026.

Improvements in diagnostic methods for the diagnosis of genetic and chronic diseases are highly prioritized all across the globe. There are lots of advancements pertaining to the effective diagnosis of genetic diseases; however, there remains a lack of adoption of technologically advanced equipment in emerging economies. Most of the developing economies in the world still opt for manual instruments in the field of research and diagnostics on account of financial feasibility.

Competitive Landscape

The growth of the NGS sample preparation market can be majorly attributed to major manufacturers of NGS sample preparation products, along with the service providers, who are actively involved in undertaking significant business strategies to translate success in research and development into the commercial clinical setting. Enterprises, led by the market juggernauts, are frequently updating and developing their respective product and service portfolios with innovative solutions to sustain the high competition in the market. Additionally, competitors' activities also include several partnerships, collaborations, and joint ventures to expand individual product and service portfolios along with the global footprint. Based on region, North America holds the largest share in the market owing to the technological advancements in NGS sample preparation methods, improved healthcare infrastructure, rise in per capita income, and improvised reimbursement policies in the region. However, the Asia-Pacific region is anticipated to grow at the fastest CAGR during the forecast period 2021-2026.

FAQ's

What is the estimated growth rate of the NGS sample preparation market in the coming years?

The global NGS sample preparation market is projected to reach $3,279.3 million by 2026, growing from $1,468.9 million in 2020, at a CAGR of 14.24% during the forecast period 2021-2026.

Which are the top market players operating in the NGS sample preparation market?

The top market players are Agilent Technologies, Inc., Aurora Biomed Inc., Danaher, Bio-Rad Laboratories, Inc., Eppendorf SE, Opentrons, BGI Group, Promega Corporation, Oxford Nanopore Technologies plc., F. Hoffmann-La Roche Ltd, Tecan Trading AG, Hamilton Company, PerkinElmer Inc., Illumina, Inc., Thermo Fisher Scientific Inc., New England Biolabs, QIAGEN, Pacific Biosciences of California, Inc.

What are the factors driving the growth of the NGS sample preparation market?

Factors driving the growth of the NGS sample preparation market are increasing use of NGS for genetic disorders, technological advancements in NGS sample preparation methods, and rising research funding in the field of genomics.

What are the challenges restricting the growth of the NGS sample preparation market?

Some of the main challenges restricting the growth of the NGS sample preparation market are the high cost of automated NGS sample preparation instruments, the dearth of skilled professionals and lack of infrastructure in emerging countries, and stringent regulatory standards.

What are some of the opportunities in the NGS sample preparation market?

The potential opportunities that are likely to boost the growth of the NGS sample preparation market are the adoption of automated NGS sample preparation in the emerging markets and rising direct-to-consumer testing.

You may also like

Published Year:2021

Transcriptomics Market - A Global and Regional Analysis: Focus on Product, Application, Technology,

The global transcriptomics market is projected to reach $33.68 billion by 2031 from $4.47...

Published Year:2019

Global Next-Generation Sequencing Market: Focus on Products and Services, Applications, Technology,

In 2018, the global next-generation sequencing market was valued at $4.93 billion and is...

Published Year:2018

Global NGS Informatics and Clinical Genomics Market: Focus on Product Types (LIMS, Data Analysis and

As of 2019, the global NGS informatics and clinical genomics market was estimated to be...

NGS Sample Preparation Market - A Global and Regional Analysis

Focus on Product, Workflow, Therapeutic Area, Application, End User, and Region - Analysis and Forecast, 2021-2026